UK Government to launch first ever men’s health strategy
As Men’s Health Awareness Month comes to an end, UK Health Secretary Wes Streeting has announced the development of a…
Male Health
-
-
FDA accepts UroGen’s UGN-102 NDA for bladder cancer treatment
UroGen Pharma has received the new drug application (NDA) acceptance from the US Food and Drug Administration (FDA) for UGN-102…
-
Diabetic macular oedema market expected to reach $9.6bn across 7MM by 2031
The diabetic macular oedema (DMO) market is expected to grow at a compound annual growth rate (CAGR) of 6.0% over…
-
£40m GLP-1RA pilot scheme for obesity to begin in the UK
Earlier this month, plans were announced in the UK for a pilot programme to take measures on obesity. This £40m…
-
US FDA grants approval for Orion-Bayer’s Nubeqa combo for prostate cancer
The US Food and Drug Administration (FDA) has granted approval for a supplemental New Drug Application (sNDA) of Orion and its partner Bayer’s…
-
How close are we to getting a male contraceptive?
With advances in clinical studies evaluating male contraceptives, and laws restricting abortion access after Roe v. Wade was overturned in…
-
Approach to spur testosterone production instead of synthesis on the horizon
Low testosterone in men is a widespread clinical problem linked to obesity, high blood pressure and Type 2 diabetes. Nearly…
-
Concerns over safety on fertility are unfounded for Covid-19 vaccines
Achieving herd immunity to Covid-19 has been made difficult by internet disinformation campaigns. One such speculative idea is that Covid-19…
-
Breaking the taboo: disrupting the fertility sector
Infertility, defined by the World Health Organization as a disease of the reproductive system that results in disability, has long…
-
Black US men have higher risk of breast cancer than white men
Breast cancer is a malignant tumour that originates in the breast tissue. Most breast cancers are invasive tumours that have…
